Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

2.300

+0.110 (5.02%)

At close: Oct 20, 2026, 4:00 PM EDT

2.350

+0.050 (2.17%)

Pre-market: Oct 21, 2026, 4:00 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Radiopharmaceutical development	884.00K	1.45M	1.43M			-	-
Isotope-Based Medical Devices	-	-	-			10.05M	9.68M
Total	884.00K	1.45M	1.43M			10.05M	9.68M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
United States	884.00K	1.45M	1.43M			10.05M	9.68M
Non - United States	-	-	-			5.03K	3.87K
Total	884.00K	1.45M	1.43M			10.05M	9.68M